Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.21 USD | +1.28% | +6.06% | -25.89% |
Financials (USD)
Sales 2024 * | 26.32M | Sales 2025 * | 155M | Capitalization | 2.02B |
---|---|---|---|---|---|
Net income 2024 * | -260M | Net income 2025 * | -219M | EV / Sales 2024 * | 69.3 x |
Net cash position 2024 * | 193M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 12.3 x |
P/E ratio 2024 * |
-8.2
x | P/E ratio 2025 * |
-10.1
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | +1.28% | ||
1 week | +6.06% | ||
Current month | +4.17% | ||
1 month | -5.37% | ||
3 months | -22.64% | ||
6 months | -10.26% | ||
Current year | -25.89% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 22.23 | +1.37% | 523,597 |
24-06-03 | 21.93 | +2.86% | 654,963 |
24-05-31 | 21.32 | -0.61% | 554,881 |
24-05-30 | 21.45 | +3.82% | 683,734 |
24-05-29 | 20.66 | -1.34% | 908,061 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.89% | 1.99B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- RCKT Stock